Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.
Br J Haematol. 2014 Jul;166(1):77-83. doi: 10.1111/bjh.12846. Epub 2014 Mar 25.
Br J Haematol. 2014.
PMID: 24661044
Free PMC article.
Clinical Trial.
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.
Mato AR, Foon KA, Feldman T, Schuster SJ, Svoboda J, Chow KF, Valentinetti M, Mrkulic M, Azzollini K, Gadaleta G, Bhattacharyya PK, Zenreich J, Pascual LN, Yannotti K, Kdiry S, Howlett C, Strelec L, Porter D, Bejot C, Goy A.
Mato AR, et al. Among authors: bejot c.
Am J Hematol. 2015 Jun;90(6):487-92. doi: 10.1002/ajh.23983. Epub 2015 Mar 30.
Am J Hematol. 2015.
PMID: 25691474
Free article.
Clinical Trial.
Item in Clipboard
Targeting indolent non-Hodgkin lymphoma.
Leslie LA, Skarbnik AP, Bejot C, Stives S, Feldman TA, Goy AH.
Leslie LA, et al. Among authors: bejot c.
Expert Rev Hematol. 2017 Apr;10(4):299-313. doi: 10.1080/17474086.2017.1303374. Epub 2017 Mar 15.
Expert Rev Hematol. 2017.
PMID: 28277849
Review.
Item in Clipboard
Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.
Goy A, Berger M, Ford P, Feldman T, Mato A, Bejot C, Fung HC.
Goy A, et al. Among authors: bejot c.
Leuk Lymphoma. 2014 Dec;55(12):2932-4. doi: 10.3109/10428194.2014.900760. Epub 2014 Apr 22.
Leuk Lymphoma. 2014.
PMID: 24611663
No abstract available.
Item in Clipboard
Cite
Cite